![](/img/cover-not-exists.png)
Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks
Gomez-Mancilla, B., Brand, R., Jurgens, T. P., Gobel, H., Sommer, C., Straube, A., Evers, S., Sommer, M., Campos, V., Kalkman, H. O., Hariry, S., Pezous, N., Johns, D., Diener, H.-C.Volume:
34
Language:
english
Journal:
Cephalalgia
DOI:
10.1177/0333102413499648
Date:
February, 2014
File:
PDF, 272 KB
english, 2014